The present invention provides a composition for preventing, improving or treating periodontal diseases comprising extract of mangosteen.

The composition of the present invention has excellent anti-bacterial and anti-inflammatory effects against bacteria inducing periodontal diseases as comprising extract of mangosteen, or alpha-mangosteen or gamma-mangosteen derived from thereof, and thereby it can be widely used for medicines and foods for preventing, improving or treating periodontal diseases.

The present invention provides a composition for preventing, improving or treating periodontal diseases comprising extract of mangosteen.

The composition of the present invention has excellent anti-bacterial and anti-inflammatory effects against bacteria inducing periodontal diseases as comprising extract of mangosteen, or alpha-mangosteen or gamma-mangosteen derived from thereof, and thereby it can be widely used for medicines and foods for preventing, improving or treating periodontal diseases.

The present description relates to a skin ointment or topical composition for skin rejuvenation and/or repair. The composition generally comprises: a biocompatible mixture of probiotics (e.g., probiotic yeast and/or bacteria); admixed with one or more of: exfoliating agents, mud and/or clay, blood circulation promoting agent, and nutrients. Methods, uses and kits relating to same are also described.

The present description relates to a skin ointment or topical composition for skin rejuvenation and/or repair. The composition generally comprises: a biocompatible mixture of probiotics (e.g., probiotic yeast and/or bacteria); admixed with one or more of: exfoliating agents, mud and/or clay, blood circulation promoting agent, and nutrients. Methods, uses and kits relating to same are also described.

Compositions and methods for the treatment of skin disorders or disease are provided.

Compositions and methods for the treatment of skin disorders or disease are provided.

Improved dermal filler formulation comprising a hyaluronic acid and a botulinum toxin.

Improved dermal filler formulation comprising a hyaluronic acid and a botulinum toxin.

Described herein are compositions in nanofiber form including one or more bioactive compounds releasably incorporated thereon. In one embodiment a composition is described comprising at least one nanofiber and at least one bioactive compound. The nanofibers are formed from a base material that is solubilized with the bioactive or bioactives in an aqueous based solvent solution and the base material and bioactives are together spun via electrospinning to form dry fibers with the bioactives chemically bonded to the nanofibers and the bioactives remaining stable during storage of the composition under ambient conditions substantially free of moisture. On exposure to moisture, the nanofibers dissolve, thereby releasing the bioactives.

Described herein are compositions in nanofiber form including one or more bioactive compounds releasably incorporated thereon. In one embodiment a composition is described comprising at least one nanofiber and at least one bioactive compound. The nanofibers are formed from a base material that is solubilized with the bioactive or bioactives in an aqueous based solvent solution and the base material and bioactives are together spun via electrospinning to form dry fibers with the bioactives chemically bonded to the nanofibers and the bioactives remaining stable during storage of the composition under ambient conditions substantially free of moisture. On exposure to moisture, the nanofibers dissolve, thereby releasing the bioactives.